About Us

The CONQUER Program

The CONQUER community-of-care initiative is an online learning tool that offers a holistic journey for patients and clinicians who are living with, diagnosing, and managing diseases driven by type 2 inflammation. Severity and control of such diseases, including chronic obstructive pulmonary disease (COPD), asthma, eosinophilic esophagitis (EoE), atopic dermatitis (AD), chronic rhinosinusitis with nasal polyps (CRSwNP), prurigo nodularis (PN), bullous pemphigoid (BP), and chronic spontaneous urticaria (CSU), can potentially benefit from advancements in targeting key cellular and signaling elements specific to the type 2 inflammatory process. The tools you’ll find here will help patients to better understand their disease and enable clinicians to improve their diagnostic and referral skills, as well as their ability to provide individualized, targeted treatment.

About Med Learning Group

Med Learning Group is a full-service, accredited medical education company focused on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care. Our goal is to provide high-quality education designed to deliver the highest level of outcomes for both the patient and the practitioner through increased competence, practice evolution, and enhanced patient care. Our major focus is the creation of leading-edge educational programs designed with scientific rigor, fair balance, and evidence-based content.

Pin It on Pinterest

Directory
Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers